<DOC>
	<DOCNO>NCT02069821</DOCNO>
	<brief_summary>The purpose study assess pharmacokinetic interaction amlodipine besylate/valsartan atorvastatin single co-administered healthy volunteer .</brief_summary>
	<brief_title>Pharmacokinetic Interactions Between Amlodipine Besylate/Valsartan Atorvastatin Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>1 . Male volunteer age 20 45 year old 2 . The weight 55kg exceed ±20 % ideal weight Ideal weight = [ height 100 ] *0.9 3 . Subjects history significant chronic disease 4 . Judged good health basis routine laboratory data obtain prior study drug administration 5 . Willing adhere protocol requirement sign inform consent form 1 . Subjects Symptoms acute disease within 28days prior study medication dose 2 . Subjects history gastrointestinal disease might significantly change ADME medicine 3 . Subjects history clinically significant allergy include drug allergy anaphylaxis amlodipine , valsartan and/or atorvastatin 4 . Subjects history myopathy 5 . Subjects hereditary problem , example , galactose intolerance , Lapp lactase deficiency glucosegalactose malabsorption 6 . Subject mean blood pressure siDBP ≥ 150 mmHg ≤ 90 mmHg and/or siSBP ≥ 95 mmHg ≤ 50 mmHg screen visit 7 . Subjects abnormal HDLcholesterol ( &lt; 35mg/dL ) 8 . Subjects abnormal serum potassium concentration ( &lt; 3.4 mEq/L &gt; 5.5 mEq/L screen visit ) 9 . Subjects history drug abuse 10 . Subjects take inducer inhibitor drug metabolism enzyme barbital within 28days prior study medication dose 11 . Subjects receive drug might confound result trial base medical judgement investigator within 14days prior drug administration OTC vitamin within 7days prior drug administration 12 . Participated previous clinical trial within 60 day prior dose 13 . Donated blood within 60 day prior dose 14 . Subjects history alcohol abuse ( 21 units/week , 1 unit = 10 g pure alcohol ) difficult stop drinking within study 15 . Subjects ever smoke 10 cigarette per day within 3 month prior drug administration 16 . Subjects history caffeine abuse difficult stop drinking within study 17 . Subjects biliary obstruction 18 . Subjects hepatic dysfunction ( AST ALT &gt; 3 time accept normal range ) 19 . Subjects moderate renal dysfunction ( creatinine clearance ( CLcr ) &lt; 30mL/min ) 20 . Subjects consider unsuitable base medical judgement investigator</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>